Ethyl 5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylate2,2,2-trifluoroacetate, 95%, 250mg

(S)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid>98.0%(HPLC)(T)25g

2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide, 97.0%, 1g

tert-Butyl (S)-2-formylmorpholine-4-carboxylate, 95%, 500mg

Electroporation cuvettes 850 µl, 50 pcs 50 pcs

3-OXO-4-ANDROSTENE-17�-CARBOXYLIc acid, 98.0%, 100g

2-METHOXY-5-PIPERAZIN-1-YL-PHENOL, 97.0%, 1g

6-HEPTYL-1-ISOPROPYL-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID, 95.0%, 250mg

Cyclohexylsulfonyl chloride, 95.0%, 1g

2-(8-Ethynylnaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

Pentanoic acid methyl-(2-methylamino-ethyl)-amide, 98.0%, 5g

2,6-Dichloro-4-(piperidin-1-ylcarbonyl)pyridine, 95.0%, 100mg

Methyl 4-(bromomethyl)-2-fluorobenzoate, 95.0%, 1g